Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure.
暂无分享,去创建一个
E. Braunwald | D. Baim | W. Grossman | E. S. Monrad | J. Parker | J. Parker | J. Edelson | E. Monrad | J. Edelson | A. McDowell | J. Cherniles
[1] E. Sonnenblick,et al. Sustained Hemodynamic and Clinical Effects of a New Cardiotonic Agent, WIN 47203, in Patients with Severe Congestive Heart Failure , 1983, Circulation.
[2] J. Cohn,et al. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. , 1983, The American journal of cardiology.
[3] W. Voelker,et al. Hemodynamic Effects of Prenalterol in Patients with Ischemic Heart Disease and Congestive Cardiomyopathy , 1982, Circulation.
[4] D C Harrison,et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. , 1982, The New England journal of medicine.
[5] N. Taira,et al. Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle. , 1982, The Journal of pharmacology and experimental therapeutics.
[6] K. Weber. New hope for the failing heart. , 1982, The American journal of medicine.
[7] E. Sonnenblick,et al. Long-term amrinone therapy in patients with severe heart failure: drug-dependent hemodynamic benefits despite progression of disease. , 1982, The American journal of medicine.
[8] E. Sonnenblick,et al. Acute Substantial Benefit of Inotropic Therapy with Amrinone on Exercise Hemodynamics and Metabolism in Severe Congestive Heart Failure , 1981, Circulation.
[9] E. Braunwald,et al. Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol. , 1981, The New England journal of medicine.
[10] E. Sonnenblick,et al. Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failure. , 1981, The American journal of cardiology.
[11] A. Fishman,et al. Amrinone and exercise performance in patients with chronic heart failure. , 1981, The American journal of cardiology.
[12] E. J. Brown,et al. Acute Effects of Oral Pirbuterol on Myocardial Oxygen Metabolism and Systemic Hemodynamics in Chronic Congestive Heart Failure , 1981, Circulation.
[13] E. Sonnenblick,et al. Beneficial Effects of Amrinone‐Hydralazine Combination on Resting Hemodynamics and Exercise Capacity in Patients with Severe Congestive Heart Failure , 1981, Circulation.
[14] B. Pitt,et al. Hemodynamic effects of intravenous prenalterol in severe heart failure. , 1981, The American journal of cardiology.
[15] J. Satriano,et al. The effects of amrinone on transport and cyclic AMP metabolism in toad urinary bladder. , 1981, The Journal of pharmacology and experimental therapeutics.
[16] J. Parker,et al. Effects of amrinone, a cardiotonic drug, on calcium movements in dog erythrocytes. , 1980, The Journal of clinical investigation.
[17] R. Loutzenhiser,et al. Ca2+ movements in smooth muscle. , 1980, Chest.
[18] E. Braunwald,et al. Effects of amrinone on experimental acute myocardial ischaemic injury. , 1980, Cardiovascular research.
[19] E. Braunwald,et al. Effects of Amrinone on Myocardial Energy Metabolism and Hemodynamics in Patients with Severe Congestive Heart Failure Due to Coronary Artery Disease , 1980, Circulation.
[20] E. Braunwald,et al. Oral amrinone in refractory congestive heart failure. , 1980, The American journal of cardiology.
[21] W. Hillis,et al. Haemodynamic effects of prenalterol in patients with coronary heart disease. , 1980, British heart journal.
[22] E. Sonnenblick,et al. Sustained beneficial effects of oral amrinone on cardiac and renal function in patients with severe congestive heart failure. , 1980, The American journal of cardiology.
[23] L. Horwitz,et al. Reliability of the maximum derivatives of left ventricular pressure and internal diameter as indices of the inotropic state of the depressed myocardium. , 1979, Cardiovascular research.
[24] G. Y. Lesher,et al. Cardiotonic Activity of Amrinone–Win 40680 [5‐Amino‐3,4f‐bipyridin‐6(lH)‐one] , 1979, Circulation research.
[25] E. Sonnenblick,et al. Amrinone A New Non-Glycosidic, Non-Adrenergic Cardiotonic Agent Effective in the Treatment of Intractable Myocardial Failure in Man , 1979, Circulation.
[26] E. Braunwald,et al. Hemodynamic assessment of amrinone. A new inotropic agent. , 1978, The New England journal of medicine.
[27] A. Katz. A new inotropic drug: its promise and a caution. , 1978, The New England journal of medicine.
[28] J. Goodwin,et al. Beneficial Effect of Salbutamol on Cardiac Function in Severe Congestive Cardiomyopathy: Effect on Systolic and Diastolic Function of the Left Ventricle , 1978, Circulation.
[29] A. Alousi,et al. New cardiotonic agents: a search for digitalis substitute. , 1978, Life sciences.
[30] J. Cohn,et al. Vasodilator Therapy of Cardiac Failure , 1977 .
[31] R R Miller,et al. Combined Dopamine and Nitroprusside Therapy in Congestive Heart Failure: Greater Augmentation of Cardiac Performance by Addition of Inotropic Stimulation to Afterload Reduction , 1977, Circulation.
[32] W. Abelmann,et al. Digitalis intoxication. , 1971, Lancet.